AXGN Axogen, Inc. Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
12:14
Aug 26
Aug 26
News wire reports multiple price target cuts across a broad set of stocks including DKS, INTU.
News wire reports multiple price target cuts across a broad set of stocks including DKS, INTU, and SYRE, alongside new coverage initiations and resumptions from various analysts.
17:32
Jan 08
Jan 08
Axogen's Avance FDA approval may improve insurance reimbursement.
The author argues Axogen's Avance nerve graft received FDA approval last month. They expect insurers to treat an FDA-approved product more favorably for reimbursement. This reimbursement shift could benefit Axogen this year.
HIGH
About AXGN Investor Commentary
Across the available history and selected sources, Buzzberg tracks AXGN (Axogen, Inc.) across 2 sources: 1 bullish vs 0 bearish calls from 2 authors. Historical directional balance: 50% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 2 total trade ideas tracked. Latest voices: DeItaone, u/surveytiger.